Jianzhijia Pharmaceutical Chain Group Co., Ltd. Share Price

Equities

605266

CNE100004JG5

Drug Retailers

End-of-day quote Shanghai S.E. 23:00:00 29/04/2024 BST 5-day change 1st Jan Change
47.74 CNY -0.50% Intraday chart for Jianzhijia Pharmaceutical Chain Group Co., Ltd. +2.89% -19.63%

Financials

Sales 2024 * 11.69B 1.61B 129B Sales 2025 * 14.45B 2B 159B Capitalization 6.15B 850M 67.82B
Net income 2024 * 511M 70.58M 5.63B Net income 2025 * 635M 87.71M 7B EV / Sales 2024 * 0.53 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 0.43 x
P/E ratio 2024 *
12 x
P/E ratio 2025 *
9.69 x
Employees 15,663
Yield 2024 *
2.03%
Yield 2025 *
2.49%
Free-Float 48.36%
More Fundamentals * Assessed data
Dynamic Chart
Jianzhijia Pharmaceutical Chain Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
JZJ Chain Drugstore Acquires 69 Pharmacies For 46 Million Yuan MT
Certain A Shares of Yunnan Jianzhijia Health-Chain Co., Ltd. are subject to a Lock-Up Agreement Ending on 1-DEC-2023. CI
Jianzhijia Pharmaceutical Chain Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Mianyang Jianzhijia Pharmacy Chain Co., Ltd. announced that it has received CNY 55 million in funding from Jianzhijia Pharmaceutical Chain Group Co., Ltd. CI
Yunnan Zhijia Convenience Store Co., Ltd. announced that it has received CNY 45 million in funding from Jianzhijia Pharmaceutical Chain Group Co., Ltd. CI
Sichuan Jianzhijia Chain Pharmacy Co., Ltd. announced that it has received CNY 35 million in funding from Jianzhijia Pharmaceutical Chain Group Co., Ltd. CI
Guangxi Jianzhijia Pharmacy Chain Co., Ltd. announced that it has received CNY 53 million in funding from Jianzhijia Pharmaceutical Chain Group Co., Ltd. CI
Sichuan Qinkang Jianzhijia Pharmaceutical Co., Ltd. announced that it has received CNY 20 million in funding from Jianzhijia Pharmaceutical Chain Group Co., Ltd. CI
Chongqing Jianzhijia Health Pharmacy Chain Co., Ltd. announced that it has received CNY 350 million in funding from Jianzhijia Pharmaceutical Chain Group Co., Ltd. CI
Yunnan Jianzhijia Chongqing Qinkang Pharmaceutical Co., Ltd. announced that it has received CNY 50 million in funding from Jianzhijia Pharmaceutical Chain Group Co., Ltd. CI
Jianzhijia Pharmaceutical Chain Group Co., Ltd.(XSSC:605266) added to S&P Global BMI Index CI
Jianzhijia Pharmaceutical Chain Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Yunnan Zhijia Convenience Store Co., Ltd. announced that it expects to receive CNY 45 million in funding from Jianzhijia Pharmaceutical Chain Group Co., Ltd. CI
Sichuan Qinkang Jianzhijia Pharmaceutical Co., Ltd. announced that it expects to receive CNY 20 million in funding from Jianzhijia Pharmaceutical Chain Group Co., Ltd. CI
More news
1 day-0.50%
1 week+2.89%
Current month+7.31%
1 month+7.31%
3 months-7.32%
6 months-6.63%
Current year-19.63%
More quotes
1 week
42.76
Extreme 42.76
48.18
1 month
42.76
Extreme 42.76
48.18
Current year
42.76
Extreme 42.76
63.37
1 year
42.76
Extreme 42.76
67.10
3 years
30.43
Extreme 30.426
76.06
5 years
30.43
Extreme 30.426
78.06
10 years
30.43
Extreme 30.426
78.06
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 31/08/04
Director of Finance/CFO 47 14/02/16
Corporate Officer/Principal 49 01-14
Members of the board TitleAgeSince
Director/Board Member 56 11/01/22
Director/Board Member 59 30/12/20
Chief Executive Officer 57 31/08/04
More insiders
Date Price Change Volume
30/04/24 47.74 -0.50% 1,067,004
29/04/24 47.98 +0.61% 1,755,851
26/04/24 47.69 +3.63% 1,836,392
25/04/24 46.02 +3.16% 1,194,970
24/04/24 44.61 -2.30% 1,495,805

End-of-day quote Shanghai S.E., April 29, 2024

More quotes
JZJ Chain Drugstore Corp is a China-based company principally engaged in chain retail business. The Company operates primarily through two segments. The Pharmaceutical Retail segment is mainly engaged in the retail of Chinese medicinal materials, health foods, personal care products, home health products and medical equipment. The Convenience Retail segment is mainly engaged in the sales of convenience products such as convenience foods and daily consumables. The Company is also engaged in the provision of professional services to pharmaceutical and convenience providers, as well as the provision of physical examination services to patients. The Company principally conducts its businesses in the domestic market.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
47.74 CNY
Average target price
69.3 CNY
Spread / Average Target
+45.16%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 605266 Stock